Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
Author:
Publisher
Elsevier BV
Subject
Ophthalmology,General Medicine
Reference9 articles.
1. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014
2. The PD-1 pathway in tolerance and autoimmunity;Francisco;Immunol Rev,2010
3. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res,2004
4. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int Immunol,2007
5. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. When Uveitis and Hypotony Meets Bilateral Iris Retraction Syndrome: A Rare but Serious Complication of Nivolumab Treatment;Case Reports in Ophthalmology;2024-07-12
2. A Case of Optic Neuritis and Posterior Uveitis with a Nodular Lesion in a Patient with Non-small-cell Lung Cancer Treated with Nivolumab Plus Ipilimumab Combined with Pemetrexed Plus Carboplatin;Haigan;2024-02-20
3. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04
4. Hypotony and Anterior Uveitis following Dual Therapy with Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report;Journal of Current Ophthalmology;2023-07
5. Update on Immune Checkpoint Inhibitor-Associated Uveitis;Current Ophthalmology Reports;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3